![]() |
| Credit: National Cancer Institute |
Scientific Frontline: Extended "At a Glance" Summary: Neuroblastoma Chemotherapy Resistance
The Core Concept: Neuroblastoma tumors develop resistance to chemotherapy by altering their cellular behavior to mimic resilient, immature embryonic cells rather than relying on new genetic mutations.
Key Distinction/Mechanism: Unlike resistance driven purely by genetic alteration, this mechanism utilizes phenotypic plasticity; the cancer cells rapidly adapt to environmental stress by reverting to a fetal development state that is naturally less responsive to conventional drugs targeting rapidly dividing cells.
Origin/History: Identified by researchers Adriana Mañas and Daniel Bexell at Lund University, and published in Science Advances, the discovery was made possible by developing a novel in vivo mouse model containing human neuroblastoma tumor cells.
.jpg)
.jpg)
.jpg)








.jpg)


.jpg)